Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older

International Journal of Geriatric Psychiatry

Volumn 21, Issue 9, 2006, Pages 898-901

  Nelson, J Craig ^a   Hollander, Steven B ^b   Betzel, James ^b   Smolen, Philip ^b   Agronin, M ^c   Bermingham, R ^c   Bertino, J ^c   Chess, D ^c   Cranmer, K ^c   Detrinis, R ^c   Gelman, L ^c   Hawa, J ^c   Irvin, E C ^c   Kopyt, N ^c   Levy, M ^c   Marchello, V ^c   Miller, L ^c   Reddy Pasem, S ^c   Rapp, K ^c   Rosanwo, A ^c   Salzman, C ^c   Segal, S ^c   Shepard, M ^c   Siegal, A ^c   Tomas, D ^c   Usher, L ^c   Watt, C K ^c   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Organon USA   (United States)

^c NONE

Author keywords

Late life depression; Mirtazapine; Nursing home

Indexed keywords

MIRTAZAPINE;

ACCIDENTAL INJURY; AGED; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG USE; FALLING; FEMALE; HAMILTON SCALE; HEALTH PRACTITIONER; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NURSING HOME PATIENT; NURSING STAFF; OPEN STUDY; PHYSICIAN; SCORING SYSTEM; SIDE EFFECT; TABLET DISINTEGRATION; TREATMENT WITHDRAWAL; URINARY TRACT INFECTION; WEIGHT GAIN;

ADMINISTRATION, ORAL; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; MIANSERIN; NURSING HOMES; PSYCHIATRIC STATUS RATING SCALES; TABLETS; TREATMENT OUTCOME;

EID: 33749317195     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1589     Document Type: Article

References (23)

1. Alexopoulos GS, Abrams RC, Young RC, et al. 1988. Cornell Scale for Depression in Dementia. Biol Psychiatry 23(3): 271-284.
2. Burrows AB, Satlin A, Salzman C, et al. 1995. Depression in a long-term care facility: clinical features and discordance between nursing assessment and patient interviews. J Am Geriatr Soc 43(10): 1118-1122.
3. Centers for Disease Control and Prevention. 2005. Web-based Injury Statistics Query and Reporting System (WISQARS). National Center for Injury Prevention and Control, Centers for Disease Control and Prevention. Available at: www.cdc.gov/ncipc/ wisqars. Accessed March 22, 2005.
4. De Boer T. 1996. The pharmacologic profile of mirtazapine. J Clin Psychiatry 57 (Suppl. 4):19-25.
5. 2- adrenoreceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 253: R5-R6.
6. Fawcett J, Barkin RL. 1998. A meta-analysis of eight randomized, double-blind controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. J Clin Psychiatry 59: 123-127.
7. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-198.
8. Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology. ECDEU Assessment Manual for Psychopharmacology. Publication ADM 76-338. US Department of Health, Education, and Welfare: Washington, DC; 218-222.
9. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiat 23: 56-62,
10. Holm KJ, Markham A. 1999. Mirtazapine: a review of its use in major depression. Drugs 57: 607-631.
11. Jones RN, Marcantonio ER, Rabinowitz T. 2003. Prevalence and correlates of recognized depression in U.S. nursing homes. J Am Geriatr Soc 51: 1404-1409.
12. Linn BS, Linn MW, Gurel L. 1968. Cumulative illness rating scale. J Am Geriatr Soc 16: 622-626.
13. Nelson JC, Roose SP, Salzman C, et al. 2005. Are there predictors of outcome to mirtazapine orally disintegrating tablets in depressed elderly nursing home residents? Presented at the annual meeting of the American Association for Geriatric Psychiatry, March 2005, San Diego, California.
14. NIH. 1991. Diagnosis and treatment of depression in late life. NIH Consens Statement Online 1991 Nov 4-6: [accessed November 11, 2003]; 9(3): 1-27.
15. Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H. 2003. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home. Cur Med Res Opin 19(8): 737-746.
16. Rubenstein LZ, Josephson KR, Robbins AS. 1994. Falls in the nursing home. Ann Intern Med 121: 442-451.
17. Salzman C. 1999. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. J Clin Psychiatry 60 ( Suppl. 20):30-33.
18. Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM, the Mirtazapine vs. Paroxetine Study Group. 2002. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 10: 541-550.
19. Sheeran T, Brown EL, Nassisi P, Bruce ML. 2004. Does depression predict falls among home health patients? Home Healthcare Nurse 22: 385-389.
20. Stahl S, Zivkov M, Reimitz PE, Panagides J, et al. 1997. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression. Acta Psychiatr Scand Suppl. 391: 22-30.
21. Street JS, Clark WS, Gannon KS, et al. 2006. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's Disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 57: 908-976.
22. Tariot PN, Cummings JL, Katz IR, et al. 2001. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc 49: 1590-1599.
23. Tinetti ME, Baker DI, McAvay G, et al. 1994. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 331: 821-827.